Expert Analysis

Head and Neck Cancer

Source: CCO Independent Conference Coverage of the 2007 American Society of Clinical Oncology Annual Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Head and Neck Cancer

Faculty:

James A. Bonner, MD
Marshall Posner, MD
Everett Vokes, MD

Robert S. Mocharnuk, MD

CREDIT INFORMATION

Release Date: August 09, 2007

Expiration Date: August 08, 2008

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.3 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the prognostic significance of epidermal growth factor receptor overexpression in the setting of head and neck cancer
Summarize the relevance of the human papillomavirus to head and neck cancer
Discuss the role of chemoradiotherapy in the treatment of patients with head and neck cancer
Discuss the use of monoclonal antibodies in the treatment of head and neck cancer

Topics covered include:

EGFR as a prognostic indicator in head and neck cancer
Magnetic resonance imaging as a prognostic technique
The relevance of human papillomavirus in head and neck cancer
Alternating, sequential, and combined chemoradiotherapy
Intensity-modulated radiotherapy in nasopharyngeal carcinoma
Chemotherapy following a complete response to induction therapy
Cetuximab treatment of advanced head and neck cancer
Anti-EGFR antisense therapy
Novel agents for thyroid cancer

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.